RESEARCHERS from the
University of Washington/Seattle
have found that intranasal insulin,
may help to improve cognitive
functioning in Alzheimer’s
sufferers.
Over a four month period the
researchers trialed either a placebo
or 20 or 40 IU of daily intranasal
insulin treatments on 109 patients.
Those patients taking insulin
showed significant improvements
in cognitive and functional tests
(up to two months after the testing
concluded) compared to those who
were taking placebos.
“We believe that restoring
normal insulin function in the brain
may provide therapeutic benefits to
adults with Alzheimer’s,” said
researcher Suzanne Craft.The above article was sent to subscribers in Pharmacy Daily's issue from 15 Jul 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 15 Jul 10
THE Pharmaceutical Society of Australia (PSA) awarded Brooke Shelly the prestigious 2024 PSA MIMS Credentialed Pharmacist of the Year award last Fri at the Credentialed Pharmacist Conference (CPC24) (PD breaking news).
THE Pharmaceutical Society of Australia (PSA) has unveiled a comprehensive membership package designed to provide robust support for credentialed pharmacists throughout their professional journey.
MEDICAL research produces better outcomes when people with lived experience are involved in the process, according to Breast Cancer Network Australia (BCNA).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.